We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Sigudu, Themba Titus![]() |
|
dc.contributor.author | Oguttu, James Wabwire![]() |
|
dc.contributor.author | Qekwana, Daniel N.![]() |
|
dc.date.accessioned | 2025-02-17T07:41:21Z | |
dc.date.available | 2025-02-17T07:41:21Z | |
dc.date.issued | 2024-09-09 | |
dc.description | DATA AVAILABILITY STATEMENT : The data supporting this study’s findings are available upon reasonable request and subject to specific conditions. For data access inquiries, including requests for collaboration or data-sharing agreements, please contact Thomas Papo, data analyst, at thomas.papo@nhls.ac.za. Requests will be evaluated on a case-by-case basis, considering the request’s nature, compliance with relevant regulations, and any associated agreements or protocols. | en_US |
dc.description.abstract | Antimicrobial resistance (AMR) poses a significant worldwide health challenge associated with prolonged illnesses, increased healthcare costs, and high mortality rates. The present study examined the patterns and predictors of AMR among human Staphylococcus isolates obtained from diagnostic laboratories in South Africa between 2012 and 2017. This study examined data from 404 217 isolates, assessing resistance rates across different characteristics such as age, sample origin, Staphylococcus species, and study period. The highest resistance was observed against cloxacillin (70.3%), while the lowest resistance was against Colistin (0.1%). A significant (p < 0.05) decreasing trend in AMR was observed over the study period, while a significant increasing temporal trend (p < 0.05) was observed for multidrug resistance (MDR) over the same period. A significant (p < 0.05) association was observed between specimen type, species of organism, and year of isolation with AMR outcome. Significant (p < 0.05) associations were observed between specimen type and season with MDR. The observed high levels of AMR and a growing trend in MDR are concerning for public health. Clinicians should take these findings into account when deciding on therapeutic options. Continued monitoring of AMR among Staphylococcus spp. and judicious use of antimicrobials in human medicine should be promoted. | en_US |
dc.description.department | Paraclinical Sciences | en_US |
dc.description.librarian | am2024 | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.uri | https://www.mdpi.com/journal/microorganisms | en_US |
dc.identifier.citation | Sigudu, T.T.; Oguttu, J.W.; Qekwana, D.N. Antimicrobial Resistance of Staphylococcus spp. from Human Specimens Submitted to Diagnostic Laboratories in South Africa, 2012–2017. Microorganisms 2024, 12, 1862. https://DOI.org/10.3390/microorganisms12091862. | en_US |
dc.identifier.issn | 2076-2607 | |
dc.identifier.other | 10.3390/microorganisms12091862 | |
dc.identifier.uri | http://hdl.handle.net/2263/100969 | |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.rights | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. | en_US |
dc.subject | Staphylococcus | en_US |
dc.subject | Isolates | en_US |
dc.subject | Human | en_US |
dc.subject | Species | en_US |
dc.subject | Antimicrobial resistance (AMR) | en_US |
dc.subject | Multidrug resistance (MDR) | en_US |
dc.subject | South Africa (SA) | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | Antimicrobial resistance of Staphylococcus spp. from human specimens submitted to diagnostic laboratories in South Africa, 2012–2017 | en_US |
dc.type | Article | en_US |